Barclays
AORT icon

Barclays’s Artivion AORT Stock Holding History

Barclays’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$295K Sell
8,047
-57,656
-88% -$2.27M ﹤0.01% 3480
2025
Q4 		$3M Buy
65,703
+11,087
+20% +$494K ﹤0.01% 2641
2025
Q3 		$2.31M Sell
54,616
-19,520
-26% -$736K ﹤0.01% 2785
2025
Q2 		$2.31M Buy
74,136
+22,830
+44% +$618K ﹤0.01% 2738
2025
Q1 		$1.26M Sell
51,306
-20,391
-28% -$566K ﹤0.01% 2962
2024
Q4 		$2.05M Buy
71,697
+820
+1% +$22.7K ﹤0.01% 2852
2024
Q3 		$1.89M Buy
70,877
+54,996
+346% +$1.43M ﹤0.01% 2899
2024
Q2 		$407K Sell
15,881
-20,757
-57% -$465K ﹤0.01% 3164
2024
Q1 		$775K Sell
36,638
-29,050
-44% -$541K ﹤0.01% 3313
2023
Q4 		$1.17M Buy
65,688
+42,663
+185% +$663K ﹤0.01% 3320
2023
Q3 		$349K Buy
23,025
+3,458
+18% +$56K ﹤0.01% 3003
2023
Q2 		$336K Sell
19,567
-299
-2% -$4.4K ﹤0.01% 2987
2023
Q1 		$260K Buy
19,866
+733
+4% +$9.37K ﹤0.01% 3649
2022
Q4 		$232K Sell
19,133
-3,679
-16% -$44.2K ﹤0.01% 3762
2022
Q3 		$316K Sell
22,812
-8,448
-27% -$170K ﹤0.01% 2944
2022
Q2 		$590K Sell
31,260
-18,802
-38% -$363K ﹤0.01% 2750
2022
Q1 		$1.07M Sell
50,062
-17,254
-26% -$333K ﹤0.01% 2341
2021
Q4 		$1.37M Buy
67,316
+19,503
+41% +$393K ﹤0.01% 2618
2021
Q3 		$1.07M Buy
47,813
+20,306
+74% +$523K ﹤0.01% 2753
2021
Q2 		$781K Sell
27,507
-22,652
-45% -$617K ﹤0.01% 2821
2021
Q1 		$1.13M Buy
50,159
+4,142
+9% +$101K ﹤0.01% 2691
2020
Q4 		$1.09M Buy
46,017
+366
+0.8% +$7.42K ﹤0.01% 2699
2020
Q3 		$843K Buy
45,651
+11,858
+35% +$227K ﹤0.01% 2832
2020
Q2 		$647K Buy
33,793
+2,986
+10% +$63.3K ﹤0.01% 3128
2020
Q1 		$522K Sell
30,807
-24,370
-44% -$625K ﹤0.01% 3542
2019
Q4 		$1.49M Buy
55,177
+13,064
+31% +$321K ﹤0.01% 3290
2019
Q3 		$1.14M Sell
42,113
-29,377
-41% -$832K ﹤0.01% 3528
2019
Q2 		$2.14M Buy
71,490
+40,531
+131% +$1.2M ﹤0.01% 2821
2019
Q1 		$902K Buy
30,959
+18,042
+140% +$515K ﹤0.01% 3508
2018
Q4 		$366K Sell
12,917
-41,116
-76% -$1.24M ﹤0.01% 4100
2018
Q3 		$1.9M Buy
54,033
+31,305
+138% +$1.01M ﹤0.01% 2940
2018
Q2 		$634K Buy
22,728
+11,890
+110% +$300K ﹤0.01% 3718
2018
Q1 		$218K Sell
10,838
-458
-4% -$8.76K ﹤0.01% 4758
2017
Q4 		$217K Buy
11,296
+10,523
+1,361% +$211K ﹤0.01% 4611
2017
Q3 		$18K Sell
773
-3,995
-84% -$80.5K ﹤0.01% 5833
2017
Q2 		$94K Sell
4,768
-7,891
-62% -$141K ﹤0.01% 4951
2017
Q1 		$211K Buy
12,659
+8,454
+201% +$149K ﹤0.01% 4259
2016
Q4 		$81K Buy
4,205
+3,825
+1,007% +$69.7K ﹤0.01% 4885
2016
Q3 		$7K Buy
+380
New +$5.75K ﹤0.01% 5900
2016
Q2 		– Sell
-2,610
Closed -$26K – 6302
2016
Q1 		$26K Buy
2,610
+1,610
+161% +$16.4K ﹤0.01% 5107
2015
Q4 		$10K Sell
1,000
-10,507
-91% -$110K ﹤0.01% 5386
2015
Q3 		$106K Sell
11,507
-1,457
-11% -$15.2K ﹤0.01% 4587
2015
Q2 		$143K Sell
12,964
-954
-7% -$10.1K ﹤0.01% 4397
2015
Q1 		$138K Sell
13,918
-2,348
-14% -$25.9K ﹤0.01% 4619
2014
Q4 		$179K Buy
16,266
+1,166
+8% +$12.1K ﹤0.01% 4738
2014
Q3 		$139K Sell
15,100
-1,192
-7% -$11.7K ﹤0.01% 5059
2014
Q2 		$130K Sell
16,292
-1,017
-6% -$9.35K ﹤0.01% 5208
2014
Q1 		$157K Sell
17,309
-29,249
-63% -$300K ﹤0.01% 5026
2013
Q4 		$511K Buy
46,558
+2,681
+6% +$25.2K ﹤0.01% 4072
2013
Q3 		$307K Sell
43,877
-5,873
-12% -$39.8K ﹤0.01% 4609
2013
Q2 		$311K Buy
+49,750
New +$304K ﹤0.01% 4742

Other funds holding AORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Barclays's AORT Position: Q1 2026 in Review

Barclays reduced its Artivion (AORT) stake by 88% in Q1 2026, selling an estimated $2.27M and leaving 8,047 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #3480.

Barclays first reported a position in AORT in Q2 2013 and has held it in 51 quarters since. The position peaked at $3M in Q4 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Barclays held 8,047 shares of Artivion worth $295K as of Q1 2026.
  • Barclays sold 57,656 Artivion shares in Q1 2026, an estimated $2.27M.
  • Artivion made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3480 holding.
  • Barclays first reported a position in Artivion in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Artivion position peaked at $3M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.